RE: IQE investor MACOM up 18%8 May 2026 12:58
In yesterday’s conference call MACOM management were very bullish on continued growth. Regarding the IQE investment they said they said:
You people may not be familiar with IQE, they are a U.K.-based company that provides epitaxial services, and recently they went through a fundraising event where MACOM participated. They raised 80 million GBP. We participated with a 45 million GBP investment. Just to break that out very quickly, it was 30 million in equity for about 11% ownership, and a 15 million GBP convertible note. Ultimately, what we did as part of this transaction is put in place a long-term supply agreement to make sure that we have adequate supply of the technologies that we’re currently acquiring from them and from others.
The why we did it really revolves around your question, which is, you know, what is MACOM doing to ensure we have strong supply chain security and resiliency? I think this is a great example of a strategic transaction, which is going to sure up not only our business regarding indium phosphide, but also the silicon carbide. Where we stand right now with that is it’s going through regulatory approval. There’ll be a shareholder vote, and it’s expected to close in the next 30 to 60 days.